Harbin Gloria Pharmaceuticals Co., Ltd.

Harbin Gloria Pharmaceuticals Co., Ltd.

Harbin Gloria Pharmaceuticals Co., Ltd.

Overview
Date Founded

2000

Headquarters

No. 29 Beijing Road,Limin Economic & Tech Dev Zone,Hulan District,Harbin, Heilongjiang 150025

Type of Company

Public

Employees (Worldwide)

2,640

Industries

Pharmaceuticals
Wholesale: Consumer Non-Durables/Sundries

Company Description

Harbin Gloria Pharmaceuticals Co., Ltd. engages in the research and development of biological products. It offers cardiovascular, cerebrovascular and skeletal muscular treatment, and antitumor and nutritional drugs. The company products include creatine phosphate sodium injections, clopidogrel bisulfate tablets, cerebroprotein hydrolysate injections, cervus and cucumis polypeptide injections, calcium levofolinate injections, and potassium and magnesium aspartate injections. Harbin Gloria Pharmaceuticals was founded on March 27, 2000 and is headquartered in Harbin, China.

Contact Data
Trying to get in touch with decision makers at Harbin Gloria Pharmaceuticals Co., Ltd.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Deputy Chairman

Chief Financial Officer & Director

Director-Business Development

Board of Directors

Chairman at Harbin Gloria Pharmaceuticals Co., Ltd.

Deputy Chairman at Harbin Gloria Pharmaceuticals Co., Ltd.

Chief Financial Officer & Director at Harbin Gloria Pharmaceuticals Co., Ltd.

Independent Director at Harbin Gloria Pharmaceuticals Co., Ltd.

Chairman at Shanghai Sailing Capital Management Co. Ltd.

Paths to Harbin Gloria Pharmaceuticals Co., Ltd.
Potential Connections via
Relationship Science
You
Harbin Gloria Pharmaceuticals Co., Ltd.
Owners & Shareholders
Details Hidden

ZhongJiang is an active manager which provides customers a range of investment alternatives across financial markets, industries and regions.

Details Hidden

CAITC is an active, risk-aware manager which invests in equities and fixed-income across sectors and market-caps. Their geographic focus is on Aisa.

Details Hidden

CAITC is an active, risk-aware manager which invests in equities and fixed-income across sectors and market-caps. Their geographic focus is on Aisa.

Recent Transactions
Details Hidden

Harbin Gloria Pharmaceuticals Co., Ltd. purchases Hefei Tianmai Biotechnology Development Co., Ltd.

Details Hidden

Shanxi C&Y Pharmaceutical Group Co., Ltd. purchases Shanxi Pude Pharmaceutical Co., Ltd. from Harbin Gloria Pharmaceuticals Co., Ltd.

Details Hidden

Harbin Gloria Pharmaceuticals Co., Ltd. purchases Shanxi Pude Pharmaceutical Co., Ltd. from Lhasa Puhua Advance Investment Co., Ltd.

Transaction Advisors
Underwriter

Advised onHarbin Gloria Pharmaceuticals Co., Ltd. issued A Shares

Clients

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. The firm compete in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Key Stats and Financials As of 2017
Market Capitalization
$10.8B
Total Enterprise Value
$17.8B
Earnings Per Share
$0.14
Revenue
$2.99B
Net Profit
$310M
EBITDA
$699M
EBITDAMargin
23.42%
Total Debt
$3.58B
Total Equity
$4.25B
Enterprise Value Sales
5.98x
Enterprise Value EBITDAOperating
25.52x
TEVNet Income
57.63x
Debt TEV
0.2x
Three Year Compounded Annual Growth Rate Of Revenue
16.66%
Five Year Compounded Annual Growth Rate Of Revenue
33.6%
Investments
Details Hidden

Shanghai Hotmed Sciences Co. Ltd. provides pharmaceutical research and development solutions and services. The firm offers medical research and development, including R&D of the novel drug, modernization of traditional Chinese medicine and R&D of generic drug. The company was founded in 2000 and is headquartered in Shanghai, China.

Investors
Details Hidden

New Horizon Advisors-HK is an active manager which invests in high growth listed (non tradable A shares) and pre-IPO Chinese companies in a range of sectors including petrochemical, energy, media, high-technology, consumer products, pharmaceutical, medical technology and automotive. They prefer to invest in companies which have built specialty positions in their industry or possess unique resources, aiming to identify investment opportunities generated from the PRC stock reform and market mechanism adjustment.The firm invests in shares of excellent listed companies and acquires existing equity interest or establishes joint ventures/partnerships with unlisted companies that demonstrate high growth potential. They seek to invest in high technology companies with an outstanding management team, competitive advantage, good corporate governance, established sales channels, high barriers to entry and unique technology.New Horizon Advisors-HK values the cooperative relationship with their investee companies, the PRC government and their overseas investment partners and seeks to add value to their investee companies by leveraging the investment experience, overseas resources network and project management skills of Tamasek Holdings and SBI Holdings.The firm generally holds an investment for two to five years.

Suppliers
Cumberland Pharmaceuticals, Inc. Biotechnology | Nashville, Tennessee

Cumberland Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. Its product include Acetadote, Caldolor, Kristalose, Hepatoren, Vaprisol, Boxaban, Vasculan, Ethyol, Portaban, and Totect. The company was founded by A. J. Kazimi on January 6, 1999 and is headquartered in Nashville, TN.

Boryung Pharmaceutical Co., Ltd. Pharmaceuticals | Seoul, SL

Boryung Pharmaceutical Co., Ltd. engages in the manufacture of of drug products. Its main products include Kanarb, Dukarb, Tuvero, TODULA, BESTO, and gelfosM. Its products include cardiovascular, antibiotics, anticancer, amino acid, cosmetics, gastrointestinal, and API. The company was founded on November 11, 1963 and is headquartered in Seoul, South Korea.

Lepu Medical Technology (Beijing) Co., Ltd. Medical Products & Equipment | Beijing, BE

Lepu Medical Technology (Beijing) Co. Ltd. engages in the research, development, production, and sale of medical equipment and accessories. Its products include medical equipment such as stent systems, occluders, interventional cardiology products, including rapamycin-eluting stents, percutaneous transluminal coronary angioplasty (PTCA) balloon dilatation catheters, guide wires and radial artery compression tourniquets; occlusion devices, including ductus arteriosus occlusion devices, ventricular septal defect occlusion devices and atrial septal defect occlusion devices, among others; anesthetic products, including blood pressure transducers, central venous catheters and infusion pumps; general medical care products, including blood sampling kits, needle-free connectors and accessories, as well as medical equipment and peripheral vascular interventional products. The company was founded on June 11, 1999 and is headquartered Beijing, China.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Harbin Gloria Pharmaceuticals Co., Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Harbin Gloria Pharmaceuticals Co., Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Harbin Gloria Pharmaceuticals Co., Ltd..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/harbin-gloria-pharmaceuticals-co-ltd-1179839
  • https://relationshipscience.com/organization/harbin-gloria-pharmaceuticals-co-ltd-1179839